Provided by Tiger Trade Technology Pte. Ltd.

Cogent

18.05
-1.9700-9.84%
Post-market: 18.190.1414+0.78%19:57 EDT
Volume:4.01M
Turnover:73.04M
Market Cap:903.62M
PE:-4.75
High:20.03
Open:20.03
Low:18.02
Close:20.02
52wk High:69.63
52wk Low:15.96
Shares:50.06M
Float Shares:48.25M
Volume Ratio:4.43
T/O Rate:8.30%
Dividend:3.05
Dividend Rate:16.90%
EPS(TTM):-3.8009
EPS(LYR):-3.8009
ROE:-229.15%
ROA:-2.07%
PB:-14.15
PE(LYR):-4.75

Loading ...

Cogent Communications Holdings Inc. Announces Annual Stockholders Meeting

Reuters
·
9 hours ago

Cogent Communications Is Maintained at Sector Perform by RBC Capital

Dow Jones
·
Mar 18

Cogent price target lowered to $22 from $23 at RBC Capital

TIPRANKS
·
Mar 18

RBC Lowers Price Target on Cogent Communications Holdings to $22 From $23, Keeps Sector Perform Rating

MT Newswires Live
·
Mar 18

Cogent Comms (CCOI) Gets a Hold from RBC Capital

TIPRANKS
·
Mar 18

Cogent Biosciences Coverage Assumed by Jefferies at Buy

Dow Jones
·
Mar 17

Cogent Biosciences assumed with a Buy at Jefferies

TIPRANKS
·
Mar 16

Cogent Biosciences Announces FDA Acceptance of New Drug Application for Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)

GlobeNewswire
·
Mar 16

Cogent CEO Dave Schaeffer to present at New Street x BCG Global Connectivity Leaders Conference

Reuters
·
Mar 13

Insider Shake-Up: Top Cogent Executives Quietly Cash Out Shares

TIPRANKS
·
Mar 06

Cogent Communications Director Sheryl Lynn Kennedy Reports Disposal of Common Shares

Reuters
·
Mar 06

Cogent Communications CFO Thaddeus Gerard Weed Disposes of Common Shares

Reuters
·
Mar 06

Cogent Communications Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Mar 06

U.S. RESEARCH ROUNDUP-Broadcom, CNX Resources, Veeva Systems

Reuters
·
Mar 05

Is Cogent Communications (CCOI) Balancing Dividend Commitments And Ongoing Losses Or Sending Mixed Signals?

Simply Wall St.
·
Mar 03

Cogent announces additional results from SUMMIT trial of bezuclastinib

TIPRANKS
·
Mar 02

Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting

GlobeNewswire
·
Feb 28

These Analysts Slash Their Forecasts On Cogent Communications After Q4 Results

Benzinga
·
Feb 24

Cogent price target lowered to $25 from $30 at KeyBanc

TIPRANKS
·
Feb 23

Oppenheimer Cuts Price Target on Cogent Communications Holdings to $30 From $40, Keeps Outperform Rating

MT Newswires Live
·
Feb 23